These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27463209)

  • 1. Heterogeneity of CD5 Membrane Expression on B-Chronic Lymphocytic Leukemia Cells.
    Kay NE; Peterson L
    Leuk Lymphoma; 1991; 5(1):49-55. PubMed ID: 27463209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
    Cabezudo E; Carrara P; Morilla R; Matutes E
    Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CD43 in B-cell chronic lymphocytic leukemia].
    Roliński J; Rupniewska ZM; Dmoszyńska A; Wasik-Szczepanek E; Bojarska-Junak A
    Pol Arch Med Wewn; 1999 Sep; 102(3):753-62. PubMed ID: 10949882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant B cell CD5 membrane phenotype and B cell colony growth in vivo and in vitro in patients with B-chronic lymphocytic leukemia: analysis with clinical parameters.
    Hings I; Kay NE; Ranheim E; Seroogy C; Parson RE
    Leuk Lymphoma; 1993 Dec; 12(1-2):59-67. PubMed ID: 7512855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of CD5 antigen in B and T cells from umbilical cord blood, from blood of healthy adults and patients with chronic lymphocytic B-cell leukemia (PBL-B)].
    Roliński J; Rupniewska ZM; Wasik-Szczepanek E
    Pol Arch Med Wewn; 1999 Apr; 101(4):307-14. PubMed ID: 10740408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
    Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
    Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD5 negative B-cell chronic lymphocytic leukemia: clinical and biological features of 42 cases.
    Cartron G; Linassier C; Bremond JL; Desablens B; Georget MT; Fimbel B; Luthier F; Dutel JL; Lamagnere JP; Colombat P
    Leuk Lymphoma; 1998 Sep; 31(1-2):209-16. PubMed ID: 9720730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
    Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD5 and CD21 molecules are a functional unit in the cell/substrate adhesion of B-chronic lymphocytic leukemia cells.
    Bergui L; Tesio L; Schena M; Riva M; Malavasi F; Schulz T; Marchisio PC; Caligaris-Cappio F
    Eur J Immunol; 1988 Jan; 18(1):89-96. PubMed ID: 3278912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
    Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
    Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of CD5+ B cells: a frame of reference for minimal residual disease analysis in chronic lymphocytic leukemia.
    Gupta R; Jain P; Deo SV; Sharma A
    Am J Clin Pathol; 2004 Mar; 121(3):368-72. PubMed ID: 15023041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of monoclonal antibodies OK-CLL (anti-CD5) with peripheral blood cells of patients with B cell lymphoproliferative disorders.
    Milosević D; Marinković M; Jelić S; Colović M; Spuzić I
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):23-9. PubMed ID: 8744680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic and surface membrane phenotypic markers in cells of B cell chronic lymphocytic leukemia.
    Koníková E; Babusíková O; Mesárosová A; Kusenda J; Glasová M
    Neoplasma; 1994; 41(2):69-74. PubMed ID: 8208317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.
    Durrieu F; Geneviève F; Arnoulet C; Brumpt C; Capiod JC; Degenne M; Feuillard J; Garand R; Kara-Terki A; Kulhein E; Maynadié M; Ochoa-Noguera ME; Plesa A; Roussel M; Eghbali H; Truchan-Graczyk M; de Carvalho Bittencourt M; Feugier P; Béné MC
    Cytometry B Clin Cytom; 2011 Nov; 80(6):346-53. PubMed ID: 21976156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological Features of CD5+ CD19+ B1 Cell and Natural IgM (VH4-34) in Chronic Lymphocytic Leukemia vs. Multiple Sclerosis.
    Pezeshki S; Jazayeri MH; Chahardouli B; Tajik N; Nabavi SM; Akbarzadeh M
    Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):670-676. PubMed ID: 36640058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL.
    Lavabre-Bertrand T; Janossy G; Exbrayat C; Bourquard P; Duperray C; Navarro M
    Leukemia; 1994 Sep; 8(9):1557-63. PubMed ID: 7522294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.